The main objectives of Muscular Dystrophy Canada are to support the autonomy of people with neuromuscular disease and to fund research project aimed at defeating these diseases. Muscular Dystrophy Canada is presently funding a research project to develop a treatment for oculo-pharyngeal muscular dystrophy.

For over 10 years, the Foundation des jumelles Coudé has contributed to the research on hereditary sensory and motor neuropathy (HSMN) performed in Dr. Rouleau’s Lab. During this period, over one million dollars have been invested in research on this disease. The Fondation’s contribution leads to the identification of the gene responsible for HSMN and to the development of a molecular diagnostic test. The current research project is aimed at characterizing the cellular mechanisms that lead to symptoms of this severe form of neuropathy.

The Fonds de recherche du Québec - Santé (FRQS) is a non-profit funding agency created by the Gouvernement du Québec. Its mandate is to implement government strategy with respect to human health research as presented in the Québec Research and Innovation Strategy. The FRQS was established in 1964 by Québec's health department under the name Conseil de recherches médicales. FRQS is now playing a leading role in planning and coordinating the development of health research in Québec through allocation of $100 million annually in awards and grants for public-sector research into human health carried out today in universities and hospital-based research centres.

Genome Canada - a not-for-profit organization established in February 2000 - was given a mandate by the Government of Canada to develop and implement a national strategy for supporting large-scale genomics and proteomics research projects, for the benefit of all Canadians. In eight years, much has been accomplished. Genome Canada adopted a bold, yet systematic approach which focuses its activities exclusively in the areas of genomics and proteomics research with an emphasis on the delivery of tangible and measurable results. This approach has positioned Canada among the world leaders in the following fields of expertise for genomics and proteomics research such as: human health, agriculture, environment, forestry, fisheries, and new technology development. Furthermore, Genome Canada continues to play a leadership role on the ethical, environmental, economic, legal and social issues (GE3LS) associated with genomics and proteomics research. Since 2000, the Canadian federal government has invested $840 M in Genome Canada, to which has been added close to $1.0 billion in partnered co-funding and interest earnings. This additional funding was secured through the development of collaborative relationships and partnerships with the private, public and venture philanthropist organizations both in Canada and abroad to jointly finance large-scale genomics and proteomics research projects.

Génome Québec is a major Quebec initiative to promote research and the development of genomics in human health, forestry, agriculture, fisheries, the environment and bioinformatics. By focusing on a national genomics research project, it brings together industry, governments, universities, hospitals, research institutes, and the general public and promotes the study of genomic issues as they relate to ethics, law and society.

The Canadian Institutes of Health Research (CIHR) is the major federal agency responsible for funding health research in Canada. Their mission is to excel in the creation of new knowledge on health and its application in the real world to improve the health of Canadians, provide better products and services and strengthen health system in Canada. Over the years, the CIHR has contributed to several research projects undertaken in Dr. Guy Rouleau’s lab including the development of a treatment for oculo-pharyngeal muscular dystrophy, the study of the molecular mechanisms of diseases caused by CAG triplets, the identification of genes causing Restless Legs Syndrome, and the study hereditary sensory and autonomic neuropathy type 2.

Volunteer-based health charity, the Heart and Stroke Foundation leads in eliminating heart disease and stroke and reducing their impact through contributing actively to the advancement of research and its application, the promotion of healthy living and through advocacy. In 2010, across Canada, the Heart and Stroke Foundation has invested close to $ 60 million in research.

Founded by a group of individuals with OCD in 1986, the mission of the International OCD Foundation is to educate the public and professional communities about OCD and related disorders; to provide assistance to individuals with OCD and related disorders, their family and friends; and to support research into the causes and effective treatments of OCD and related disorders.

The Muscular Dystrophy Association (MDA) was created in 1950 by a group of adults with muscular dystrophy, parents of children with muscular dystrophy, and a physician-scientist studying the disorder. MDA combats neuromuscular diseases through programs of worldwide research, comprehensive medical and community services, and far-reaching professional and public health education. MDA has been supporting Dr. Rouleau’s research on oculo-pharyngeal muscular dystrophy amyotrophic lateral sclerosis for over 10 years.

The Restless Legs Syndrome Foundation is a non-profit organization providing the latest information about RLS. The goals of the Foundation are to increase awareness, improve treatments, and through research, find a cure for RLS, a condition which severely affects the lives of millions of individuals. The RLS Foundation is presently funding Dr. Rouleau’s research project aimed at the identification of a gene causing RLS.

The ALS Society of Canada is committed to support research towards a cure for ALS, to support provincial ALS societies in their provision of quality care for persons living with ALS and to build public awareness of ALS and its impact. The ALS Society of Canada is providing funding for Dr. Rouleau’s research on neuromuscular disorders as well as a fellowship.

Parkinson Society Canada (PSC) is a national, not-for-profit, volunteer based charity with more than 100 chapters and many support groups working nationwide. As the national voice of Canadians living with Parkinson’s disease, our purpose is to ease the burden and find a cure through research, advocacy, education and support. The PSC is presently funding a research project aimed at the identification of genes causing Parkinson’s Disease

Founded in 1972, the Tourette Syndrome Association (TSA) is the only US national voluntary non-profit membership organization in this field. Its mission is to identify the cause of, find the cure for and control the effects of Tourette Syndrome.